GBIO - Generation Bio Co.
5.34
-0.400 -7.491%
Share volume: 551,924
Last Updated: 02-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$5.74
-0.40
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-07-2024 | 11-06-2024 | 03-13-2025 | 05-07-2025 | 11-05-2025 | |
| Total revenue | 4.059 M | 4.091 M | 7.554 M | 4.188 M | 8.723 M | 1.594 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 4.059 M | 4.091 M | 7.554 M | 4.188 M | 8.723 M | 1.594 M | |
| 0.79% | 84.65% | -44.56% | 108.29% | -81.73% | |||
| Operating expenses | 24.763 M | 25.903 M | 24.269 M | 24.150 M | 24.191 M | 33.792 M | |
| Selling general and admin | 10.428 M | 9.515 M | 9.181 M | 8.656 M | 8.834 M | 12.162 M | |
| Research and development | 14.335 M | 16.388 M | 15.088 M | 15.494 M | 15.357 M | 21.630 M | |
| Total expenses | 81.693 M | 27.400 M | 25.438 M | 27.751 M | 25.329 M | 8.302 M | |
| -66.46% | -7.16% | 9.09% | -8.73% | -67.22% | |||
| Operating income | -77.634 M | -23.309 M | -17.884 M | -23.563 M | -16.606 M | -6.708 M | |
| Ebit | -77.634 M | -23.309 M | -17.884 M | -23.563 M | -16.606 M | -6.708 M | |
| Pretax income | -77.634 M | -23.309 M | -17.884 M | -23.563 M | -14.802 M | -5.520 M | |
| -69.98% | -23.27% | 31.75% | -37.18% | -62.71% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -74.541 M | -20.432 M | -15.313 M | -21.382 M | -14.802 M | -5.520 M | |
| 72.59% | 25.05% | -39.63% | 30.77% | 62.71% |